BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 10386956)

  • 1. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons.
    Akerud P; Alberch J; Eketjäll S; Wagner J; Arenas E
    J Neurochem; 1999 Jul; 73(1):70-8. PubMed ID: 10386956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons.
    Horger BA; Nishimura MC; Armanini MP; Wang LC; Poulsen KT; Rosenblad C; Kirik D; Moffat B; Simmons L; Johnson E; Milbrandt J; Rosenthal A; Bjorklund A; Vandlen RA; Hynes MA; Phillips HS
    J Neurosci; 1998 Jul; 18(13):4929-37. PubMed ID: 9634558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
    Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurturin is a neuritogenic but not a survival factor for developing and adult central noradrenergic neurons.
    Holm PC; Akerud P; Wagner J; Arenas E
    J Neurochem; 2002 Jun; 81(6):1318-27. PubMed ID: 12068079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF).
    Saarma M; Sariola H
    Microsc Res Tech; 1999 May 15-Jun 1; 45(4-5):292-302. PubMed ID: 10383122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE; Hoffman AF; Gerhardt GA; Henry MA; Biddle PT; Hoffer BJ; Granholm AC
    J Comp Neurol; 1995 May; 355(4):479-89. PubMed ID: 7636027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.
    Fjord-Larsen L; Johansen JL; Kusk P; Tornøe J; Grønborg M; Rosenblad C; Wahlberg LU
    Exp Neurol; 2005 Sep; 195(1):49-60. PubMed ID: 15919076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X; Hagg T
    J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.
    Tanriover G; Seval-Celik Y; Ozsoy O; Akkoyunlu G; Savcioglu F; Hacioglu G; Demir N; Agar A
    Folia Histochem Cytobiol; 2010 Sep; 48(3):434-41. PubMed ID: 21071351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.
    Bowenkamp KE; Lapchak PA; Hoffer BJ; Miller PJ; Bickford PC
    Exp Neurol; 1997 May; 145(1):104-17. PubMed ID: 9184114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
    Wang Y; Tien LT; Lapchak PA; Hoffer BJ
    Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
    Cass WA; Peters LE
    Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM; Gash DM
    Brain Res; 1995 Feb; 672(1-2):104-11. PubMed ID: 7749731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurturin mRNA expression suggests roles in trigeminal innervation of the first branchial arch and in tooth formation.
    Luukko K; Saarma M; Thesleff I
    Dev Dyn; 1998 Oct; 213(2):207-19. PubMed ID: 9786421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor.
    Hoane MR; Gulwadi AG; Morrison S; Hovanesian G; Lindner MD; Tao W
    Exp Neurol; 1999 Nov; 160(1):235-43. PubMed ID: 10630208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.
    Meyer M; Matarredona ER; Seiler RW; Zimmer J; Widmer HR
    Neuroscience; 2001; 108(2):273-84. PubMed ID: 11734360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS.
    Golden JP; Baloh RH; Kotzbauer PT; Lampe PA; Osborne PA; Milbrandt J; Johnson EM
    J Comp Neurol; 1998 Aug; 398(1):139-50. PubMed ID: 9703032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
    Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
    Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.